Form 4: Atlassian Co-Founder Michael Cannon-Brookes Executes Pre-Planned Stock Sales
Insider Trading Report
Atlassian Corp (TEAM) Co-Founder and CEO Michael Cannon-Brookes sold 7,665 shares of Class A Common Stock on July 7, 2025, through a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, Atlassian's Co-Founder, CEO, Director, and 10% Owner, reported the sale of 7,665 shares of Class A Common Stock.
- The transactions occurred on July 7, 2025, at weighted-average prices ranging from $211.7018 to $216.255 per share.
- These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Cannon-Brookes on February 20, 2025.
- Following these transactions, Mr. Cannon-Brookes beneficially owns 459,900 shares of Class A Common Stock indirectly through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider selling can be viewed negatively, the execution under a pre-arranged Rule 10b5-1 plan mitigates concerns about opportunistic selling based on new information, indicating a planned and orderly divestment.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, which was adopted on February 20, 2025, indicating the transactions were pre-scheduled and not based on recent non-public information.
Negatives
- Insider selling, even when pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct stake in the company.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Management Comments
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.
Industry Context
This filing is a routine disclosure of insider stock transactions, common across publicly traded companies. The use of a Rule 10b5-1 plan is a standard practice for corporate insiders to manage their stock holdings in compliance with insider trading regulations, providing a defense against claims of trading on material non-public information.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The reported stock sales were conducted under a Rule 10b5-1 trading plan, adopted on February 20, 2025. This demonstrates adherence to corporate governance best practices designed to prevent insider trading by allowing insiders to pre-schedule trades. | 02/20/2025 | Enhances transparency and reduces the perception of opportunistic trading by company insiders, aligning with regulatory expectations for orderly stock transactions. |
Related Party Transactions
- The shares beneficially owned following the reported transactions are held indirectly by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust, indicating a related party structure for holding the shares.
Stakeholder Impact
- Shareholders: May interpret the insider selling as a signal, though the 10b5-1 plan mitigates concerns about a lack of confidence. The reduction in direct insider ownership could be noted.
- Regulatory Authorities: The filing demonstrates compliance with Section 16(a) of the Securities Exchange Act of 1934 and the use of a Rule 10b5-1 plan, which is a recognized mechanism for compliant insider trading.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 07/07/2025 | Date of the reported stock transactions (sales). |
| 07/08/2025 | Date the Form 4 was signed and filed. |
Keywords
Atlassian, TEAM, Michael Cannon-Brookes, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.